ETF Holdings Breakdown of IBRX

News associated with IBRX

ImmunityBio, Inc. (NASDAQ:IBRX) Stake Reduced by Legal & General Group Plc

Legal & General Group Plc lessened its stake in shares of ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 7.8% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 131,364 shares of the company’s stock after selling 11,161 shares during the quarter. Legal & General Group Plc’s holdings in ImmunityBio were worth $336,000 at […] - 2025-05-01 08:24:53

Geode Capital Management LLC Decreases Stock Holdings in ImmunityBio, Inc. (NASDAQ:IBRX)

Geode Capital Management LLC cut its stake in ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 0.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,840,918 shares of the company’s stock after selling 5,757 shares during the period. Geode Capital Management LLC’s holdings […] - 2025-04-24 07:58:48

LPL Financial LLC Raises Stock Position in ImmunityBio, Inc. (NASDAQ:IBRX)

LPL Financial LLC grew its position in ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 67.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 257,449 shares of the company’s stock after buying an additional 103,495 shares during the period. LPL […] - 2025-04-24 07:10:54

Teacher Retirement System of Texas Has $107,000 Stock Position in ImmunityBio, Inc. (NASDAQ:IBRX)

Teacher Retirement System of Texas grew its stake in shares of ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 20.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 41,742 shares of the company’s stock after acquiring an additional 7,067 shares during the period. […] - 2025-04-03 07:54:52

Comparing ImmunityBio (NASDAQ:IBRX) & Curis (NASDAQ:CRIS)

ImmunityBio (NASDAQ:IBRX – Get Free Report) and Curis (NASDAQ:CRIS – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations. Analyst Recommendations This is a summary of recent ratings and […] - 2025-04-02 05:20:51

Stephens Inc. AR Invests $26,000 in ImmunityBio, Inc. (NASDAQ:IBRX)

Stephens Inc. AR acquired a new position in shares of ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,090 shares of the company’s stock, valued at approximately $26,000. Several other large […] - 2025-02-18 08:16:55

After Hours Most Active for Jan 27, 2025 : VTWO, NVDA, AAPL, T, QQQ, IBRX, GOOGL, BAC, AA, GAP, BABA, XOM

The NASDAQ 100 After Hours Indicator is up 67.15 to 21,194.43. The total After hours volume is currently 157,887,661 shares traded.The following are the most active stocks for the after hours session: Vanguard Russell 2000 ETF (VTWO) is +0.1 at $91.72, with 9,652,088 shares trad - 2025-01-27 21:24:58

IBRX institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-05-08	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	196,600	USD 410,894
2025-05-08	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	27,442	USD 57,354 9.6%
2025-05-08	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	253,362	USD 529,527 9.6%
2025-05-08	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	349,455	USD 730,361
2025-05-08	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	349,455	USD 730,361 9.6%
Total =		1,176,314	USD 2,458,497

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer